Perspectives on the pharmaceutical industry.
This paper seeks to provide an economic perspective on the pharmaceutical industry, which has come under increasing criticism on a number of issues. In the main, that criticism amounts to a rather ineffective flailing at the supply side of the market for pharmaceutical products-much of it based on inaccurate perceptions-when a more productive policy would be to strengthen the hitherto weak and poorly informed demand side of the market.
Reinhardt
U E
UE
Princeton University, USA.
D000066:Accounting; D003363:Cost Control; D017047:Cost Sharing; D016527:Drug Costs; D004345:Drug Industry / Q000191:economics*; D017850:Economics, Pharmaceutical; D005252:Fees, Pharmaceutical; D006801:Humans; D014481:United States